Multicenter Perioperative Opioid Pharmacogenetic Study

Key facts

Sponsor

Children's Hospital Medical Center, Cincinnati

Principal Investigator

Senthilkumar Sadhasivam

Children's Hospital Medical Center, Cincinnati

Enrollment

1000 target

Eligibility

6-17 years · All sexes

Timeline

2010 – 2017

Study locations (15)

• Children's Hospital of Los Angeles, Los Angeles, California, United States
• Stanford University Medical Center, Palo Alto, California, United States
• The Children's Hospital, Denver, Denver, Colorado, United States
• University of Miami - Miller School of Medicine, Miami, Florida, United States
• Children's Memorial Hospital, Chicago, Illinois, United States
• Ochsner Medical Center for Children, New Orleans, Louisiana, United States
• The Johns Hopkins Hospital, Baltimore, Maryland, United States
• Boston Children's Hospital, Boston, Massachusetts, United States
• C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States
• St. Louis Children's Hospital, St Louis, Missouri, United States
• Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
• St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States
• Texas Children's Hospital, Houston, Texas, United States
• Seattle Children's Hospital, Seattle, Washington, United States
• UW Health-American Family Children's Hospital, Madison, Wisconsin, United States

Collaborators

Baylor College of Medicine · Ochsner Health System · Children's Hospital Colorado · Children's Hospital Los Angeles · C.S. Mott Children's Hospital · St. Christopher's Hospital for Children · St. Louis Children's Hospital · Boston Children's Hospital · Seattle Children's Hospital · Ann & Robert H Lurie Children's Hospital of Chicago · University of Wisconsin, Madison · University of Miami · Johns Hopkins University · Stanford University · Phoenix Children's Hospital · University of Michigan · University of Utah · Shanghai Children's Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Opsoclonus-myoclonus syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07485517
  Deep Versus Moderate Neuromuscular Blocking
  Menoufia University
• ACTIVE NOT RECRUITINGNANCT07419815
  IV Lidocaine Infusion Versus Placebo for Pain Control in Staging Laparoscopy Cases
  Shaukat Khanum Memorial Cancer Hospital & Research Centre
• RECRUITINGNANCT07473648
  Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy
  The Second Hospital of Anhui Medical University
• ACTIVE NOT RECRUITINGNCT07144410
  Pain Control and Side Effects in Cesarean Section Anesthesia: Comparison of Intrathecal Morphine and Fentanyl
  University of Oradea
• RECRUITINGPHASE2NCT07036406
  Comparing Traditional Semantic Feature Analysis (tSFA) and Semantic Feature Analysis + Metacognitive Strategy Training (SFA+MST)
  Teachers College, Columbia University
• RECRUITINGPHASE3NCT06846281
  Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
  Novartis Pharmaceuticals
• RECRUITINGPHASE4NCT06797973
  Efficacy and Safety of Intrathecal Morphine for Postoperative Pain Management Following Planned Caesarean Section
  Anne Juul Wikkelsø
• RECRUITINGPHASE3NCT06847724
  Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis
  Sandoz

See all trials for Opsoclonus-myoclonus syndrome →